Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (8): 911-914.

Previous Articles     Next Articles

Preliminary study for narrowing mutant selection window of staphylococcus aureus by combination of levofloxacin and Vancomycin in vitro

LI Zhao-xia1, LIU You-ning1, WANG Rui2, TONG Wei-hang2, CHENG Shi-hu1   

  1. 1Department of Respiratory of General Hospital of PLA, 2Clinical Pharmacology Laboratory of General Hospital of PLA, Beijing 100853, China
  • Received:2007-04-29 Revised:2007-06-05 Online:2007-08-26 Published:2020-10-27

Abstract: AIM: To study whether levofloxacin and Vancomycin combination can narrow mutant selection window(MSW)of single drug group in vitro, which contribute to new strategies for restricting the development of resistance and provide data for rational applications of available antibacterial drugs in clinic practice. METHODS: Minimal antibiotic concentration(MPC)and MSWs were determined by spreading 1010 CFU/mL coccus on agar plates at different drug concentrations.MPC was defined as the lowest concentration inhibiting 100% of the coccus population after 72 h incubation. RESULTS: MSW of levofloxacin and vancomycin for staphylococcus aureus strain ATCC29213 was 16 and 64 respectively;Vancomycin combined with levofloxacin(1MIC+8MIC, 2MIC+ 4MIC)decreased the MSW of levofloxacin to staphylococcus aureus ATCC29213 for 2-4 times;Levofloxacin combined with vancomycin(1MIC+16MIC, 2MIC+8MIC) decreased the MSW of vancomycin to staphylococcus aureus ATCC29213 for 4-8 times. CONCLUSION: Combinations of levofloxacin and vancomycin can decrease MSW to staphylococcus aureus, ATCC29213 compared with individual drug administration.

Key words: levofloxacin, vancomycin, staphylococcus aureus, mutant selection window

CLC Number: